510(k) · Cleared
ClearedNitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs-Violet Blue (VBLU)
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Hartalega NGC Sdn. Bhd. · LZA Polymer Patient Examination Glove
Cleared on Mar 31, 2016 after a 255-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 3 later devices descend from it.
- Decided
- Mar 31, 2016
- Review
- 255 days
- Class
- Class I
- Product code
- LZA
- Recalls
- None
- Predicates
- 0
3 later devices descend from it, 2 citing it directly.
- This deviceK151997 Nitrile Powder Free Examination Gloves Tested for Use with…Hartalega NGC Sdn. Bhd. · 2016
- Descendant · cites it directly · 1 of its ownK222225 Nitrile Powder Free Examination Glove Tested for Use with…Hartalega NGC Sdn. Bhd. · 2022
- Descendant · 2 generations on · 0 of its ownK243818 Nitrile Powder Free Examination Glove Tested for Use with…Hartalega NGC Sdn. Bhd. · 2025
- Descendant · cites it directly · 0 of its ownK162095 Non-Sterile, Powder Free Nitrile Examination Gloves, Tested for use…Yty Industry (Manjung) Sdn Bhd · 2016
Most influential descendants
Showing 3 of 3 · See all- K222225Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs (Blue)Hartalega NGC Sdn. Bhd. · 2022 · cites it directly1descendant
- K243818Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs and…Hartalega NGC Sdn. Bhd. · 2025 · 2 generations on0descendants
- K162095Non-Sterile, Powder Free Nitrile Examination Gloves, Tested for use with Chemotherapy…Yty Industry (Manjung) Sdn Bhd · 2016 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K151997 | Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy… | Hartalega NGC Sdn. Bhd. | 2016 | — |
| +1 | K222225 | Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs… | Hartalega NGC Sdn. Bhd. | 2022 | — |
| +2 | K243818 | Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs… | Hartalega NGC Sdn. Bhd. | 2025 | — |
| +1 | K162095 | Non-Sterile, Powder Free Nitrile Examination Gloves, Tested for use with… | Yty Industry (Manjung) Sdn Bhd | 2016 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2016 | 1 | 0 |
| 2022 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LZA device
- #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
FDA’s file for it is a 510(k) statement, which names no predicate.
What descends from it? (3)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K222225 (Hartalega NGC Sdn. Bhd., 2022) has gone furthest, with 1 descendant of its own.
How does its category compare?
All LZA devicesLZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.
FDA decisions per year · LZA
24in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LZA
110in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LZA
3so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LZA
73in 2025
MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 21 | 95 | 0 | 7 |
| 2008 | 18 | 97 | 0 | 2 |
| 2009 | 28 | 112 | 0 | 12 |
| 2010 | 31 | 97 | 0 | 12 |
| 2011 | 26 | 122 | 0 | 9 |
| 2012 | 33 | 110 | 0 | 11 |
| 2013 | 20 | 130 | 0 | 10 |
| 2014 | 27 | 197 | 0 | 8 |
| 2015 | 20 | 112 | 1 | 12 |
| 2016 | 30 | 171 | 1 | 25 |
| 2017 | 44 | 124 | 0 | 4 |
| 2018 | 22 | 178 | 0 | 3 |
| 2019 | 25 | 212 | 0 | 21 |
| 2020 | 30 | 101 | 0 | 4 |
| 2021 | 139 | 111 | 0 | 20 |
| 2022 | 146 | 111 | 0 | 19 |
| 2023 | 62 | 92 | 0 | 24 |
| 2024 | 30 | 89 | 0 | 76 |
| 2025 | 24 | 110 | 0 | 73 |
| 2026 | 15 | 103 | 3 | — |
What is it indicated for?
The Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs - Violet Blue (VBLU) is nonsterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs. The list of Chemotherapy Drugs tested (with breakthrough times) is as below: Carmustine (3.3 mg/ml) 10.2 minutes Cisplatin (1.0 mg/ml) >240 minutes…
Read the full statement (140 words)
The Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs - Violet Blue (VBLU) is nonsterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs.
The list of Chemotherapy Drugs tested (with breakthrough times) is as below:
Carmustine (3.3 mg/ml) 10.2 minutes
Cisplatin (1.0 mg/ml) >240 minutes
Cyclophosphamide (20 mg/ml) >240 minutes
Dacarbazine (10.0 mglml) >240 minutes
Doxorubicin Hydrochloride (2.0 mg/ml) >240 minutes
Etoposide (20.0 mg/ml) >240 minutes
Fluorouracil (50.0 mg/ml) >240 minutes
Methotrexate (25 mg/ml) >240 minutes
Mitomycin C (0.5 mg/ml) >240 minutes
Paclitaxel (6.0 mg/ml) >240 minutes
Thiotepa (10.0 mg/ml) 30.2 minutes
Vincristine Sulfate (1.0 mg/ml) >240 minutes
Please note that Carmustine and Thiotepa have extremely low permeation times of 10.2 minutes and 30.2 minutes.
Indications for use as stated in the FDA 510(k) statement.
https://510kreport.com/device/K151997 · printed Nov 3, 2026
Cite this page
510(k) Report. “K151997: Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs-Violet Blue (VBLU).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K151997
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026